NextCure, Inc.
NXTC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001661059
In the last 90 days, NextCure, Inc. insiders filed 2 open-market purchases and 1 sale; 30 institutions reported holding it in 13F filings for Q2 2026, worth $2.78M in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding NextCure, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 71 | 59 | −12 |
| Shares | 14.4M | 13.2M | −1.13M (−7.9%) |
| Value | $86.2M | $64.3M | −$21.9M (−25.4%) |
New holders (3)
Institutions that held NextCure, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bailard, Inc. | 30,600 | $149.0K | 0.01% |
| Jane Street Group, LLC | 15,054 | $73.0K | 0.00% |
| Corton Capital Inc. | 12,662 | $62.0K | 0.03% |
Sold out (15)
Institutions that held NextCure, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Lombard Odier Asset Management (Switzerland) SA | 407,291 | $2.44M |
| Jacobs Levy Equity Management, Inc | 185,796 | $1.11M |
| Assenagon Asset Management S.A. | 125,854 | $755.0K |
| Anson Funds Management LP | 115,328 | $692.0K |
| IndexIQ Advisors LLC | 42,188 | $253.0K |
| Prelude Capital Management, LLC | 18,300 | $110.0K |
| Cubist Systematic Strategies, LLC | 18,383 | $110.0K |
| Marquette Asset Management, LLC | 17,500 | $105.0K |
| Invesco Ltd. | 15,757 | $95.0K |
| Two Sigma Investments, LP | 14,114 | $85.0K |
| Marshall Wace, LLP | 13,991 | $84.0K |
| Jump Financial, LLC | 13,700 | $82.0K |
| Public Employees Retirement System of Ohio | 6,938 | $42.0K |
| FMR LLC | 250 | $2.00K |
| Wells Fargo & Company | 25 | $0 |